Aquestive Therapeutics, Inc. AQST Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Aquestive Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The official record: Aquestive Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aquestive Therapeutics, Inc.'s total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aquestive Therapeutics, Inc.'s total current liabilities?
- Aquestive Therapeutics, Inc. (AQST) reported total current liabilities of $31.75M in Q1 2026.
- How has Aquestive Therapeutics, Inc.'s total current liabilities changed year-over-year?
- Aquestive Therapeutics, Inc.'s total current liabilities increased by 73.5% year-over-year, from $18.3M to $31.75M.
- What is the long-term trend for Aquestive Therapeutics, Inc.'s total current liabilities?
- Over 5 years (2020 to 2025), Aquestive Therapeutics, Inc.'s total current liabilities has grown at a 17.7% compound annual growth rate (CAGR), from $21.1M to $47.61M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.